Effective Management of Polycythemia Vera With Ropeginterferon Alfa-2b Treatment.
Shan Shan SuoRong Feng FuAlbert QinZong Hong ShaoJie BaiSu Ning ChenMing Hui DuanHu ZhouNa XuSu Jiang ZhangXue Lan ZuoXin DuLi WangPei LiXu Han ZhangDao Xiang WuYa Ning LiJing Jing ZhangWei WangWei Hong ShenOleh ZagrijtschukToshiaki SatoZhi Jian XiaoJie JinPublished in: Journal of hematology (2024)
The 250-350-500 µg dosing regimen was well tolerated and effectively induced CHR and MR and managed spleen size increase. Our findings demonstrate that ropeginterferon alfa-2b at this dosing regimen can provide an effective management of PV and support using this dosing regimen as a treatment option.